Pancreatic cancer resources

Pancreatic cancer resources

ORGANISATIONS

Pancreatic Cancer Alliance
The Pancreatic Cancer Alliance is a collaborative voice raising awareness of pancreatic cancer in Australia with a long-term view of increasing donor funds to support research.
Australian Pancreatic Cancer Genome Initiative (APGI)
APGI is a global research enterprise of over 100 scientists, clinicians and allied health professionals involved in pancreatic cancer research and care.
Cancer Australia
Pancreatic cancer information from the national government agency working to reduce the impact of cancer on all Australians.
Pancare Foundation
The Pancare Foundation supports world-leading research projects into pancreatic, liver, biliary, oesophageal and stomach cancers.
GI Cancer Institute
The GI Cancer Institute saves lives by funding gastro-intestinal clinical trials research in Australia.
Avner Pancreatic Cancer Foundation
The Avner Pancreatic Cancer Foundation is named after Avner Nahmani who passed away in October 2008 from pancreatic cancer. The Foundation has a vision to double the survival rate by 2020.
#PurpleOurWorld
When Rochelle Goulburn was diagnosed with pancreatic cancer, she and her family discovered that there was very little support for, and awareness of, pancreatic cancer. They have made a personal commitment to get the world talking about pancreatic cancer.

NEWS

Key support for Garvan’s cancer research in 2018 and beyond
Garvan researchers are thrilled to be among the recipients of grants in recently announced funding schemes from the National Breast Cancer Foundation and Cancer Australia.
Sydney Opera House turns purple for pancreatic cancer
On the eve of World Pancreatic Cancer Day (16 November, 2017), the Pancreatic Cancer Alliance turned the Sydney Opera House purple to raise awareness of the insidious disease.
Pancreatic cancer: Avner Foundation awards major grants to improve survival
On World Pancreatic Cancer Day, the Avner Pancreatic Cancer Foundation has awarded grants of over $900,000 to Garvan's pancreatic cancer researchers.
Pancreatic cancer: a lucky quirk in Ros’ DNA holds the key to survival
In long-term survivors of pancreatic cancer, the immune system sees the cancer as an infectious disease – and so is empowered to attack and destroy tumour cells, according to new research from the US and Australia.
Long-term survivors of pancreatic cancer have ‘built-in immunotherapy’
In long-term survivors of pancreatic cancer, the immune system sees the cancer as an infectious disease – and so is empowered to attack and destroy tumour cells, according to new research from the US and Australia.
Breakthrough breast cancer drug targets a major type of pancreatic cancer
A newly approved breast cancer drug could be highly effective against some forms of pancreatic cancer, including metastatic cancer, Australian researchers have found.
DreamLab app speeding up Garvan's cancer research
The DreamLab app, a distributed smartphone supercomputer, is now available on iOS and Android. Garvan and The Vodafone Foundation are now calling one million Australians to download the app and contribute to Garvan’s cancer research.
NHMRC funding success for Garvan
Garvan congratulates Associate Professors Shane Grey, Paul Timpson and Tim Mercer, and Dr James Wang, who have recently received NHMRC funding to carry out their research.
Biosensor mouse lights up health and disease
Garvan researchers have developed a biosensor mouse that gives a real-time readout of the rapidly changing ‘skeleton’ within cells.
A one-two punch for pancreatic cancer: ‘softening’ tumours before chemo markedly improves survival
Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it ‘softer’ and more responsive to chemotherapy.
NSW Government funding for Garvan scientists to research new treatments for breast and pancreatic cancer
Three of Garvan’s researchers have been awarded three-year Fellowships from Cancer Institute NSW to explore new ways to target breast and pancreatic cancer.
The ‘other’ pancreatic cancer: uncovering the genomic landscape of an enigmatic rare tumour
An Australian-led international research effort has revealed that genetic changes normally linked to breast, colon and ovarian cancers could also drive a rare form of pancreatic cancer.
Awareness of fifth most common cause of cancer related death in Australia is alarmingly low
One of the highest mortality rates, no screening test and few treatment options. A breakthrough in pancreatic cancer is desperately needed.
Pancreatic Cancer Alliance Brings Australian ‘Voice’ to Global Pancreatic Initiative
The Pancreatic Cancer Alliance, a collaboration of organisations and individuals committed to raising awareness of pancreatic cancer in Australia, has secured representation on the first-ever World Pancreatic Cancer Coalition (WPCC).
Genomics yields a new understanding of pancreatic cancer
A breakthrough study of over 450 pancreatic cancer genomes, published today in Nature, has shown that pancreatic cancer is in fact four distinct diseases. The study was led by researchers from the Australian Pancreatic Cancer Genome Initiative, Garvan, the University of Melbourne and the University of Queensland.
A “biosensor mouse” that can predict the spread of pancreatic cancer
Scientists from Australia and the UK have created a “biosensor mouse”, enabling them to watch as pancreatic cancer cells begin to “unzip” from each other in real time – a signal that cells are on the verge of spreading from the primary tumour. Remarkably, the researchers successfully rezipped these cancer cells by treating mice with anti-cancer therapies, stopping the spread of cancer before it had begun.
Fellowship to help fight pancreatic cancer
A major philanthropic gift to the Garvan Institute of Medical Research has helped to enable Australia’s world-class researchers to continue to fight against pancreatic cancer. The Fellowship was set-up following a $1.5 million donation to the Garvan Research Foundation made by Mr Len Ainsworth in 2015, Founder of Aristocrat Leisure and current Chairman of Ainsworth Game Technology.
Throwing light on how to conduct a personalised pancreas cancer clinical trial
Australian leaders of an ongoing pancreatic cancer clinical trial known as the Individualised Molecular Pancreatic Cancer Therapy or ‘IMPaCT’ trial, have been learning ways to bring about a new paradigm of personalised cancer care for pancreatic cancer and other aggressive cancer types.
Early detection window when pancreatic cancer is in the family
Pancreatic cancer likely takes between 10 and 20 years to develop, providing the potential for a very “broad window” of intervention if detected early, which may be possible for people who inherit a predisposition, say Australian clinical researchers.
Large-scale pancreatic genome study generates evidence for important ethical debate
Whole genome sequencing is rapidly becoming affordable for research and diagnostic purposes, yet there is still much debate surrounding the return of personal genetic information to patients or family members.
Potential treatment for a specific kind of pancreatic cancer
Garvan researchers have identified a potentially treatable subtype of pancreatic cancer, which accounts for about 2% of new cases. This subtype expresses high levels of the HER2 gene. HER2-amplified breast and gastric cancers are currently treated with Herceptin.
A step towards better understanding of pancreatic cancer
Garvan scientists, along with collaborators from Belgium and Spain, have observed that the well-studied protein Sirtuin-1, known for helping cells live longer, also appears to play an important role in the initiation and development of pancreatic cancer.

VIDEOS

Personalised Medicine for Pancreatic Cancer
Garvan's Dr Marina Pajic talks about new personalised medicine approaches for pancreatic cancer.
Pancreatic Cancer Awareness Month
Garvan's Dr Paul Timpson talks about Pancreatic Cancer Awareness Month
Understanding pancreatic cancer
Garvan's Amber Johns talks about the Australian Pancreatic Cancer Genome Initiative and our scientists’ pancreatic cancer research
3D rotation of pancreatic cancer
3D rotation of pancreatic cancer showing the fluorescent “zippering” protein E-cadherin holding tumour cells together.
Pancreatic Cancer Genome Sequencing
Garvan's Dr Marina Pajic presenting "Cancer genome sequencing: Developing personalised medicine strategies for pancreatic cancer"
Garvan's Work in Pancreatic Cancer
Professor Andrew Biankin talks about Garvan's work in pancreatic cancer.